A
Alejandro Martín
Researcher at Biotec
Publications - 33
Citations - 900
Alejandro Martín is an academic researcher from Biotec. The author has contributed to research in topics: Dengue virus & Epitope. The author has an hindex of 12, co-authored 31 publications receiving 547 citations. Previous affiliations of Alejandro Martín include University of Seville.
Papers
More filters
Journal ArticleDOI
The impact of class imbalance in classification performance metrics based on the binary confusion matrix
TL;DR: A new way to measure the imbalance is defined which surpasses the Imbalance Ratio and a set of null-biased multi-perspective Class Balance Metrics is proposed which extends the concept of Class Balance Accuracy to other performance metrics.
Journal ArticleDOI
Belowground structure and production in a Mediterranean sand dune shrub community
TL;DR: In this article, the importance of nutrients rather than water, as possible determinants of the structure and dynamics of the root system, as well as for the primary production of the community during the vegetative period, was analyzed.
Journal ArticleDOI
Clonal Distribution of Disease-Associated and Healthy Carrier Isolates of Neisseria meningitidis between 1983 and 2005 in Cuba
Yanet Climent,Daniel Yero,Isabel Martínez,Alejandro Martín,Keith A. Jolley,Franklin Sotolongo,Martin C. J. Maiden,Rachel Urwin,Rolando Pajon +8 more
TL;DR: The application of VA-MENGOC-BC, the Cuban serogroups B and C vaccine, reduced the frequency and diversity of hypervirulent clonal complexes ST-32 (vaccine serogroup B type-strain) and ST-41/44 and also affected other lineages.
Journal Article
Situación epidemiológica actual y resistencia de los patógenos respiratorios en Espan̄a
J García de Lomas,F. Baquero,Emilio Bouza,M. Casal,R. Cisterna,M. P. De La Rosa,C. Garcia-Riestra,José Angel García-Rodríguez,Miguel Gobernado,A. Gutiérrez-Altés,A.C. Gómez-García,R. Gomez-Lus,M.T. Jiménez,Alejandro Martín,Guillem Prats +14 more
Journal ArticleDOI
Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers
Antonio Pérez,Félix O Dickinson,Zurina Cinza,Aroldo Ruíz,Teresita Serrano,Jorge Sosa,Sonia González,Yainelis Gutierrez,Consuelo Nazábal,Oderay Gutiérrez,Daymi Guzmán,Manuel Diaz,Maité Delgado,Evelin Caballero,Gretel Sardiñas,Anabel Alvarez,Alejandro Martín,Gerardo Guillén,Ricardo Silva +18 more
TL;DR: A Phase I clinical trial was carried out in healthy volunteers who received three inoculations of either placebo or recombinant P64k (20 or 50 μg) and these P64K formulations were considered safe and immunogenic in healthy human volunteers.